The Effect of Poor Social Support on Depression among HIV/AIDS Patients in Ethiopia: A Systematic Review and Meta-Analysis.

Q1 Psychology
Depression Research and Treatment Pub Date : 2020-12-09 eCollection Date: 2020-01-01 DOI:10.1155/2020/6633686
Adisu Birhanu Weldesenbet, Sewnet Adem Kebede, Biruk Shalmeno Tusa
{"title":"The Effect of Poor Social Support on Depression among HIV/AIDS Patients in Ethiopia: A Systematic Review and Meta-Analysis.","authors":"Adisu Birhanu Weldesenbet,&nbsp;Sewnet Adem Kebede,&nbsp;Biruk Shalmeno Tusa","doi":"10.1155/2020/6633686","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Low- and middle-income countries of which Ethiopia is one bears the high burden of depression among human immune deficiency virus and acquired immune deficiency syndrome (HIV/AIDS) patients. Several factors have been identified as being associated with increased depression among HIV/AIDS patients including poor social support. However, studies examining the effect of poor social support on depression among HIV/AIDS patients in Ethiopia have had inconsistent findings. This systematic review and meta-analysis is therefore aimed at estimating the pooled effect of poor social support on depression among HIV/AIDS patients in Ethiopia.</p><p><strong>Methods: </strong>All relevant articles published prior to July 1, 2020, were retrieved from scientific databases: PubMed, Scopus, and Google Scholar systematically. The identified studies reporting the association of depression and poor social support among HIV patients in Ethiopia were included. <i>I</i> <sup>2</sup> tests were used to assess the heterogeneity of the studies. Subgroup analysis was done based on tools to determine how pooled estimates of depression vary across tools. The pooled estimate of association between poor social support and depression was reported.</p><p><strong>Results: </strong>The aggregated meta-analysis revealed a higher odds of depression among patients with poor social support than those who had strong social support (OR: 2.31, 95% CI: 1.69, 2.93). The pooled prevalence of depression among HIV/AIDS patients in Ethiopia was 38.93% (95%: CI: 32.01, 45.84); (<i>I</i> <sup>2</sup> = 94.44%, <i>p</i> ≤ 0.001). The subgroup analysis was performed based on tools, and the result showed that the highest pooled prevalence (44.42%) was among primary studies that used the Hospital Anxiety and Depression Scale (HADS) tool.</p><p><strong>Conclusions: </strong>Human immune deficiency virus and acquired immune deficiency syndrome (HIV/AIDS) patients with poor social support were more likely to develop depression. The pooled prevalence of depression among HIV/AIDS patient was high in Ethiopia. The highest prevalence of depression was observed among studies that used HADS to screen depression. Therefore, we recommend integration of mental health and psychosocial support services into the HIV/AIDS care. Prevention of HIV/AIDS-related stigma for people with HIV/AIDS is also needed to reduce the impact of poor social support.</p>","PeriodicalId":38441,"journal":{"name":"Depression Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/6633686","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Depression Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/6633686","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Psychology","Score":null,"Total":0}
引用次数: 13

Abstract

Background: Low- and middle-income countries of which Ethiopia is one bears the high burden of depression among human immune deficiency virus and acquired immune deficiency syndrome (HIV/AIDS) patients. Several factors have been identified as being associated with increased depression among HIV/AIDS patients including poor social support. However, studies examining the effect of poor social support on depression among HIV/AIDS patients in Ethiopia have had inconsistent findings. This systematic review and meta-analysis is therefore aimed at estimating the pooled effect of poor social support on depression among HIV/AIDS patients in Ethiopia.

Methods: All relevant articles published prior to July 1, 2020, were retrieved from scientific databases: PubMed, Scopus, and Google Scholar systematically. The identified studies reporting the association of depression and poor social support among HIV patients in Ethiopia were included. I 2 tests were used to assess the heterogeneity of the studies. Subgroup analysis was done based on tools to determine how pooled estimates of depression vary across tools. The pooled estimate of association between poor social support and depression was reported.

Results: The aggregated meta-analysis revealed a higher odds of depression among patients with poor social support than those who had strong social support (OR: 2.31, 95% CI: 1.69, 2.93). The pooled prevalence of depression among HIV/AIDS patients in Ethiopia was 38.93% (95%: CI: 32.01, 45.84); (I 2 = 94.44%, p ≤ 0.001). The subgroup analysis was performed based on tools, and the result showed that the highest pooled prevalence (44.42%) was among primary studies that used the Hospital Anxiety and Depression Scale (HADS) tool.

Conclusions: Human immune deficiency virus and acquired immune deficiency syndrome (HIV/AIDS) patients with poor social support were more likely to develop depression. The pooled prevalence of depression among HIV/AIDS patient was high in Ethiopia. The highest prevalence of depression was observed among studies that used HADS to screen depression. Therefore, we recommend integration of mental health and psychosocial support services into the HIV/AIDS care. Prevention of HIV/AIDS-related stigma for people with HIV/AIDS is also needed to reduce the impact of poor social support.

Abstract Image

Abstract Image

Abstract Image

社会支持不足对埃塞俄比亚HIV/AIDS患者抑郁的影响:系统回顾和荟萃分析。
背景:埃塞俄比亚是低收入和中等收入国家之一,在人类免疫缺陷病毒和获得性免疫缺陷综合征(艾滋病毒/艾滋病)患者中,抑郁症的负担很高。有几个因素已被确定为与艾滋病毒/艾滋病患者的抑郁症增加有关,包括社会支持不足。然而,对埃塞俄比亚艾滋病毒/艾滋病患者中缺乏社会支持对抑郁症影响的研究得出了不一致的结果。因此,本系统综述和荟萃分析旨在估计埃塞俄比亚艾滋病毒/艾滋病患者中缺乏社会支持对抑郁症的综合影响。方法:系统地从PubMed、Scopus和Google Scholar等科学数据库中检索2020年7月1日前发表的所有相关文章。已确定的研究报告了埃塞俄比亚艾滋病毒患者中抑郁症和社会支持不足的关联。采用2个检验来评估研究的异质性。亚组分析是基于工具来确定不同工具对抑郁的综合估计是如何变化的。报告了不良社会支持与抑郁之间的综合估计。结果:综合荟萃分析显示,社会支持差的患者患抑郁症的几率高于社会支持强的患者(OR: 2.31, 95% CI: 1.69, 2.93)。埃塞俄比亚艾滋病毒/艾滋病患者中抑郁症的总患病率为38.93% (95% CI: 32.01, 45.84);(I 2 = 94.44%, p≤0.001)。基于工具进行亚组分析,结果显示,在使用医院焦虑和抑郁量表(HADS)工具的主要研究中,合并患病率最高(44.42%)。结论:人类免疫缺陷病毒和获得性免疫缺陷综合征(HIV/AIDS)患者社会支持差更容易发生抑郁。在埃塞俄比亚,艾滋病毒/艾滋病患者中抑郁症的总流行率很高。在使用HADS筛查抑郁症的研究中,观察到抑郁症的患病率最高。因此,我们建议将心理健康和社会心理支持服务纳入艾滋病毒/艾滋病护理。还需要预防与艾滋病毒/艾滋病有关的对艾滋病毒/艾滋病患者的羞辱,以减少社会支持不足的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Depression Research and Treatment
Depression Research and Treatment Psychology-Clinical Psychology
CiteScore
8.80
自引率
0.00%
发文量
8
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信